Last week our team attended the 20th PGDIS conference, this time in Paris.
The aim of this conference was to present news in the field of genetic testing and to coordinate research, education and training. The owner and CEO of Repromeda, MUDr. Kateřina Veselá, Ph.D. presented the topic of PGT-M for hereditary oncogenic mutations as a part of fertility preservation and reproduction in oncology patients/carriers.
